Risk-based Regulation Proposed for DTC Genetic Tests

An opinion paper in Science argues that using a risk-based classification system and post-market surveillance would be the best approach for regulating direct-to-consumer genomics firms.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories